Insilico Medicine (03696.HK) intends to repurchase shares on the open market

Zhitong Finance APP News, Insilico Medicine (03696.HK) announced that the Company has decided to repurchase its shares from time to time on the open market of The Stock Exchange of Hong Kong Limited (the Stock Exchange) pursuant to the general mandate granted to the directors at the annual general meeting held on June 2, 2026 and approved by the Company's shareholders (the Repurchase Mandate), with an aggregate amount of up to HK$500 million (the Share Repurchase).